Paid Clinical Trials in Miami Lakes, FL
As of August 2026, 150 paid clinical trials are recruiting in Miami Lakes, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Miami Lakes offers studies at sites including Floridian Clinical Research for conditions such as Schizophrenia, Obesity, Heart Failure, Hepatic Impairment. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Miami Lakes
Trials by drug in Miami Lakes
Filter results
Newly added in Miami Lakes
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
140 clinical trials
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Study of DONQ52 in Active Celiac Disease
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Pelacarsen Roll-over Extension Program
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Top Research Study Locations in Miami Lakes
Researchers run research studies in Miami Lakes, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Floridian Clinical Research | Hepatic Impairment, Choline Deficiency, Cirrhosis | 11 |
| Panax Clinical Research | Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease | 11 |
| GSK Investigational Site | Chickenpox, Non-alcoholic Fatty Liver Disease, Pulmonary Disease, Chronic Obstructive | 9 |
| Palm Springs Community Health Center | Alzheimer Disease, Alzheimer Disease (AD), COVID-19 Vaccines | 7 |
| Floridian Clinical Research, LLC | Bipolar Disorder, Depressive Disorder, Major, Healthy Participants | 6 |
| Innovative Clinical Research, Inc. | Schizophrenia, Bipolar Disorder Type I With Mania, Bipolar Disorder Type I With Mania or Mania With Mixed Features | 5 |
| Inpatient Research Clinical LLC | Aortic Stenosis, Atherosclerotic Cardiovascular Disease, Hypercholesterolaemia | 4 |
| Indago Research & Health Center, Inc | Obesity, Overweight, Alzheimer Disease | 4 |
| Indago Research and Health Center | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Diseases | 4 |
| Wellness Clinical Research | Celiac Disease, Crohn's Disease, Moderately to Severely Active Crohn Disease | 4 |
| Inpatient Research Clinic | Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a) | 4 |
| Deluxe Health Center | Chronic Spontaneous Urticaria, Asthma, Chronic Obstructive Pulmonary Disease | 4 |
| Floridian Clinical Research LLC | Healthy Postmenopausal Women, Lupus Erythematosus, Systemic, Overweight or Obesity and Elevated Liver Fat | 3 |
| Inpatient Research Clinic LLC | Heart Failure, Atrial Fibrillation (AF), Obesity | 3 |
| Inpatient Research Clinic, LLC | Cardiovascular Disease, Heart Failure, Percutaneous Coronary Intervention | 3 |
| Praxis Research Site | Focal Seizure, Epilepsy, Tonic-Clonic, Focal Onset Seizure | 3 |
| San Marcus Research Clinic, Inc. | COPD, Lupus Erythematosus, Systemic, Nephritis, Lupus | 3 |
| Urological Research Network | Cancer of the Prostate, Neoplasms Prostate, Kidney Neoplasms | 3 |
| Design Neuroscience Center | Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic | 2 |
| Ezy Medical Research | Crohn Disease, Colitis, Ulcerative | 2 |
| Global Health Research Center, Inc. | Atopic Dermatitis, COVID-19 SARS-CoV-2 Infection | 2 |
| Innovative Clinical Research | Bipolar I Disorder, Schizophrenia | 2 |
| Neurocrine Clinical Site | Schizophrenia | 2 |
| Riveldi Biomedical Research | Autism Spectrum Disorder, Bipolar Depression, Bipolar Disorder | 2 |
| Riveldi and Associates | Pneumococcal Disease | 2 |
Active & Upcoming Studies in Miami Lakes (2026)
Recruiting trials in Miami Lakes grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Mental health & behavior (20 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia · Phase 1 · Leal Therapeutics, Inc
Diabetes & metabolic (15 active studies)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin · Phase 3 · AstraZeneca
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Cardiovascular (11 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
Neurology & pain (7 active studies)
- AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) · Phase 1 · Institute for Molecular Medicine
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Vaccines (5 active studies)
- A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age · Phase 4 · BioNTech SE
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults · Phase 1 · GlaxoSmithKline
Cancer & tumors (3 active studies)
- The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer · Phase 3 · Quercis Pharma AG
- MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer · Urological Research Network, LLC
Common conditions studied in Miami Lakes
- Schizophrenia (12 active studies)
- Obesity (5 active studies)
- Heart Failure (4 active studies)
- Hepatic Impairment (4 active studies)
- Alzheimer Disease (3 active studies)
- Bipolar I Disorder (3 active studies)
Leading research sponsors in Miami Lakes
- Eli Lilly and Company
- GlaxoSmithKline
- Pfizer
- Sanofi
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Miami Lakes?
There are approximately 150 recruiting clinical trials in Miami Lakes, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Miami Lakes pay participants?
Most recruiting trials in Miami Lakes compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Miami Lakes?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Miami Lakes?
The most common conditions under active study in Miami Lakes include Schizophrenia (12), Obesity (5), Heart Failure (4), Hepatic Impairment (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Miami Lakes?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Miami Lakes on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Miami Lakes?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Miami Lakes?
Recruiting research sites in Miami Lakes include Floridian Clinical Research, Panax Clinical Research, GSK Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Miami Lakes right now?
The largest active categories in Miami Lakes are Mental health & behavior (20), Diabetes & metabolic (15), Cardiovascular (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.